이스라엘 - 영어 - Ministry of Health

dor pharmaceutical services ltd., israel - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 100 mg/vial - bendamustine - first-line of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotheraphy is not appropiate. indolent non-hodgkin’s lymphomas as monotheraphy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen.follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.

이스라엘 - 영어 - Ministry of Health

astellas pharma international b.v., israel - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 100 mg - bendamustine - first-line of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotheraphy is not appropiate. indolent non-hodgkin’s lymphomas as monotheraphy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.

이스라엘 - 영어 - Ministry of Health

dor pharmaceutical services ltd., israel - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 25 mg/vial - bendamustine - first-line of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotheraphy is not appropiate. indolent non-hodgkin’s lymphomas as monotheraphy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.

이스라엘 - 영어 - Ministry of Health

astellas pharma international b.v., israel - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 25 mg - bendamustine - first-line of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotheraphy is not appropiate. indolent non-hodgkin’s lymphomas as monotheraphy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.

남아프리카 - 영어 - South African Health Products Regulatory Authority (SAHPRA)

roche products (pty) ltd - infusion (parenteral) - see ingredients - each vial contains obinutuzumab 1 000,0 mg

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

actavis pty ltd - azathioprine -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - azathioprine -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - azathioprine -

미국 - 영어 - NLM (National Library of Medicine)

genentech, inc. - obinutuzumab (unii: o43472u9x8) (obinutuzumab - unii:o43472u9x8) - obinutuzumab 1000 mg in 40 ml - gazyva, in combination with chlorambucil, is indicated for the treatment of patients with previously untreated chronic lymphocytic leukemia. gazyva, in combination with bendamustine followed by gazyva monotherapy, is indicated for the treatment of patients with follicular lymphoma who relapsed after, or are refractory to, a rituximab-containing regimen. gazyva, in combination with chemotherapy followed by gazyva monotherapy in patients achieving at least a partial remission, is indicated for the treatment of adult patients with previously untreated stage ii bulky, iii or iv follicular lymphoma. gazyva is contraindicated in patients with known hypersensitivity reactions (e.g., anaphylaxis) to obinutuzumab or to any of the excipients, or serum sickness with prior obinutuzumab use [see warnings and precautions (5.4)]. risk summary based on findings from animal studies and its mechanism of action, gazyva can cause fetal b-cell depletion [see clinical pharmacology (12.1)] . there are no data with gazyva use in pre

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - azathioprine -